PhD scholarship: Economic evaluation of paediatric interventions for respiratory failure
|Enrolment status||New students|
|Student type||Domestic students, International students|
|Level of study||Higher Degree by Research|
|Study area||Business and Economics, Health and Behavioural Sciences, Medicine|
|HDR funding type||Living stipend scholarship|
|Scholarship value||$28,092 per annum (2020 rate), indexed annually|
|Scholarship duration||Three years with the possibility of two 6-month extensions|
|Opening date||1 September 2020|
|Closing date||15 September 2020|
The student will join world class researchers from both the Child Health Research Centre, UQ, and the School of Economics/Centre for Business and Economics of Health, UQ. The HDR candidate will be supervised Professor Brenda Gannon.
The objective of this study is to determine the cost-effectiveness of interventions for respiratory failure across paediatric patients. Focusing on specific randomised controlled trials, the aims include establishing the cost-effectiveness of paediatric interventions for respiratory failure. The project will specifically determine the cost-effectiveness of Transnasal Humidified Rapid Insufflation Ventilatory Exchange in comparison with standard care, and the cost-effectiveness of nasal high flow therapy in comparison with standard oxygen therapy in paediatric patients. Using appropriate economic evaluations models from health economics, the project will provide estimates of cost-effectiveness. The project will investigate alternative models and parameters, focusing on the costing approach and use of administrative data.
For more information click "LINK TO ORIGINAL" below.
This opportunity has expired. It was originally published here: